MeSH D018380 - hematopoietic stem cell transplantation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Plerixafor | Plerixafor Accord |  | 2022-12-16 |  |  |
| Adienne | Melphalan | Phelinun |  | 2020-11-16 |  |  |
| Thiotepa | Tepadina |  | 2010-03-15 |  |  | |
| Esteve Pharmaceuticals | Thiotepa | Thiotepa Riemser |  | 2021-03-26 |  |  |
| Fresenius Kabi | Busulfan | Busulfan Fresenius Kabi |  | 2014-09-22 |  |  |
| Hexal | Filgrastim | Filgrastim Hexal |  | 2009-02-06 |  |  |
| Laboratoires Pierre Fabre | Busulfan | Busilvex |  | 2003-07-09 |  |  |
| medac | Treosulfan | Trecondi |  | 2019-06-20 |  |  |
| Pfizer | Filgrastim | Nivestim |  | 2010-06-07 |  |  |
| Ratiopharm | Filgrastim | Filgrastim ratiopharm |  | 2008-09-15 |  |  |
| Filgrastim | Ratiograstim |  | 2008-09-15 |  |  | |
| Sandoz | Filgrastim | Zarzio |  | 2009-02-06 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
52%12/23
Phase 2
40%10/25
Phase 3
63%10/16
Approved: 7Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use